
Cigna (CI) Stock Forecast & Price Target
Cigna (CI) Analyst Ratings
Bulls say
Cigna Group is a diversified global health service company that primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its recently completed merger with Express Scripts, are mainly sold to health insurance plans and employers. The company's strong financial performance is driven by its growing specialty and care services division, as well as its focus on cost management and strategic initiatives such as exiting the individual Affordable Care Act exchange market. In addition, Cigna's commitment to diversity and sustainability may appeal to socially responsible investors.
Bears say
Cigna Group is facing pressure from its underperforming pharmacy benefit management and health insurance services segments, which are expected to continue underperforming in the near future. The company's recent attempts to expand its PBM business through acquisitions and contracts have not translated into significant growth, leading to concerns about its ability to compete against larger players in the market. Additionally, the decision to exit the individual health insurance market in 2027 may cause short-term losses, but is a smart long-term move to focus on its more profitable core business lines.
This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.
Cigna (CI) Analyst Forecast & Price Prediction
Start investing in Cigna (CI)
Order type
Buy in
Order amount
Est. shares
0 shares